Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.
Christopher M. Blanchette, PhD
Advertisement
Articles by Christopher M. Blanchette, PhD
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
2
Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B
3
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
4
Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies
5